Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Some people are microdosing certain weight loss drugs in an attempt to reap some of the drugs' benefits with fewer of their side effects. But doctors specializing in weight loss say that ...